Sun Pharmaceutical Industries Limited (BOM:524715)
India flag India · Delayed Price · Currency is INR
1,731.60
+24.25 (1.42%)
At close: May 21, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
India Formulations
164.18B
Log In
Log In
Log In
Log In
Upgrade
India Formulations Growth
12.87%
Log In
Log In
Log In
Log In
Upgrade
US Formulations
161.74B
Log In
Log In
Log In
Log In
Upgrade
US Formulations Growth
8.34%
Log In
Log In
Log In
Log In
Upgrade
Total Formulations
488.44B
Log In
Log In
Log In
Log In
Upgrade
Total Formulations Growth
9.67%
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API)
20.12B
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients (API) Growth
6.56%
Log In
Log In
Log In
Log In
Upgrade
Others Segment
1.83B
Log In
Log In
Log In
Log In
Upgrade
Others Segment Growth
-25.38%
Log In
Log In
Log In
Log In
Upgrade
Emerging Market
91.95B
Log In
Log In
Log In
Log In
Upgrade
Emerging Market Growth
9.39%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations
70.58B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Formulations Growth
6.00%
Log In
Log In
Log In
Log In
Upgrade
Other Operating
5.64B
Log In
Log In
Log In
Log In
Upgrade
Other Operating Growth
-27.19%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is April - March.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 2012 - 2019
Sales per Medical Representative
Log In
Log In
Log In
Log In
Upgrade
Sales per Medical Representative Growth
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives
Log In
Log In
Log In
Log In
Upgrade
Number of Medical Representatives Growth
Log In
Log In
Log In
Log In
Upgrade